Outcomes, Not Dashboards

Executive summary preview

Sell a specific decision or control, not broad healthcare transformation.

The strongest consulting angles combine a measurable operational or compliance outcome with implementation, rather than standalone advice or another dashboard.

The opportunity map spans discharge capacity, promotional review, biomarker testing, prior authorisation, clinical integration and auditable governance. Each opportunity is graded by the evidence behind it, separating corroborated signals from open hypotheses.

Key findings

• Measurable outcomes have budget owners: readmission penalties give discharge engagements a concrete operational focus.
• Reconstructable promotional review processes and audit trails are valuable when enforcement raises the cost of weak controls.
• Independent bias testing offers a specific service for developers of AI-derived digital biomarkers.
• Co-development partnerships, post-merger EHR work and rural consortia have thinner evidence and rest mainly on network signals.

Research figures

81%

of US physicians used AI in practice in 2026

52.8m

Medicare Advantage prior authorisations in 2024

78%

of US hospitals face a Medicare readmission penalty in FY2026

The opportunity map: healthcare & life sciences

1. Discharge & post-acute capacity
2. Pharma promo review
3. Biomarker bias testing

12 more items fully covered in the report.

Get the free summary